Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 17.07 is 88% above its 5-year average of 9.10, near the high end of its 5-year range (4.07–17.07).
As of the fiscal period ended Wednesday, December 31, 2025. 18.95% above its 12-month average of 14.35.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 37 quarters.
EARNINGS PER SHARE (EPS)
17.07
EARNINGS PER SHARE (EPS) AVG TTM
14.35
EARNINGS PER SHARE (EPS) AVG 3Y
11.37
EARNINGS PER SHARE (EPS) AVG 5Y
9.10
EARNINGS PER SHARE (EPS) AVG 10Y
5.50
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.95%
CURRENT VS 3Y AVG
+50.16%
CURRENT VS 5Y AVG
+87.58%
CURRENT VS 10Y AVG
+210.16%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Medpace Holdings, Inc.
Market Cap
$16.11B
Earnings Per Share (EPS)
17.07
TTM Avg
14.35
3Y Avg
11.37
5Y Avg
9.10
Market Cap
$16.97B
Earnings Per Share (EPS)
2.40
TTM Avg
2.92
3Y Avg
3.22
5Y Avg
4.07
Market Cap
$14.80B
Earnings Per Share (EPS)
8.17
TTM Avg
5.85
3Y Avg
6.82
5Y Avg
7.06
Market Cap
$14.10B
Earnings Per Share (EPS)
1.18
TTM Avg
1.92
3Y Avg
1.82
5Y Avg
11.98
Market Cap
$18.17B
Earnings Per Share (EPS)
3.85
TTM Avg
4.00
3Y Avg
3.51
5Y Avg
2.55
Market Cap
$13.51B
Earnings Per Share (EPS)
-2.04
TTM Avg
-1.51
3Y Avg
-0.65
5Y Avg
0.36
Market Cap
$12.55B
Earnings Per Share (EPS)
2.10
TTM Avg
2.25
3Y Avg
2.01
5Y Avg
3.78
Market Cap
$12.11B
Earnings Per Share (EPS)
5.76
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $16.11B | 17.07 | 14.35 | 11.37 | 9.10 |
| DaVita Inc. (DVA)vs › | $15.41B | 9.94 | 10.37 | 8.56 | 8.35 |
| Hologic, Inc. (HOLX)vs › | $16.97B | 2.40 | 2.92 | 3.22 | 4.07 |
| Solventum Corporation (SOLV)vs › | $14.80B | 8.17 | 5.85 | 6.82 | 7.06 |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 1.18 | 1.92 | 1.82 | 11.98 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.17B | 3.85 | 4.00 | 3.51 | 2.55 |
| Baxter International Inc. (BAX)vs › | $13.51B | -2.04 | -1.51 | -0.65 | 0.36 |
| Revvity, Inc. (RVTY)vs › | $12.55B | 2.10 | 2.25 | 2.01 | 3.78 |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 5.76 | 5.64 | 5.43 | 9.01 |
| Viatris Inc. (VTRS)vs › | $20.45B | -0.26 | -1.77 | -0.44 | -0.66 |
Trailing EPS (TTM)
$17.07
Forward EPS (Est.)
$17.60
P/E Ratio
33.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 15.64 |
| 2024-12-31 | 13.06 |
| 2023-12-31 | 9.20 |
| 2022-12-31 | 7.57 |
| 2021-12-31 | 5.06 |
| 2020-12-31 | 4.07 |
| 2019-12-31 | 2.79 |
| 2018-12-31 | 2.05 |
| 2017-12-31 | 1.00 |
| 2016-12-31 | 0.38 |
| 2015-12-31 | -0.28 |
| 2014-12-31 | -0.53 |
| 2013-12-31 | 1.33 |
Reported annual fiscal-period values; no daily interpolation.
